• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by FOXO Technologies Inc.

    5/15/25 5:00:05 PM ET
    $FOXO
    Life Insurance
    Finance
    Get the next $FOXO alert in real time by email
    NT 10-Q 1 formnt10-q.htm NT 10-Q

     

     

     

    U.S. SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON D.C. 20549

     

    FORM 12b-25

    Commission File Number 001-39783

     

    NOTIFICATION OF LATE FILING

     

    (Check One):

    ☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR

     

    For Period Ended: March 31, 2025

       
         
    ☐ Transition Report on Form 10-K   ☐ Transition Report on Form 10-Q
    ☐ Transition Report on Form 20-F   ☐ Transition Report on Form N-SAR
    ☐ Transition Report on Form 11-K    

     

    For the Transition Period Ended:

     

    Read Attached Instruction Sheet Before Preparing Form. Please Print or Type.

     

    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     

    Part I-Registrant Information

     

    Full Name of Registrant   FOXO Technologies Inc.
         
    Former Name if Applicable  

    Delwinds Insurance Acquisition Corp.

         
    Address of principal executive office  

    477 South Rosemary Avenue, Suite 224

         
    City, State and Zip Code   West Palm Beach, FL 33401

     

     

     

     

     

     

    Part II-Rules 12b-25 (b) and (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate) ☒

     

      a. The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
         
      b. The subject annual report, semi-annual report, transition report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
         
      c. The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    Part III-Narrative

     

    State below in reasonable detail the reasons why the form 10-K, 11-K, 20-F, 10-Q or N-SAR, or the transition report or portion thereof could not be filed within the prescribed time period. (Attach extra sheets of needed.)

     

    The Company is unable to file, without unreasonable effort and expense, its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 within the prescribed time period because the Company is still completing the Form 10-Q and its auditors have not completed their review of the financial statements for the period then ended. The Company expects to file its Form 10-Q on or prior to the fifth calendar day following the prescribed due date.

     

    Part IV-Other Information

     

      1. Name and telephone number of person to contact in regard to this notification

     

      Seamus Lagan   (612)   800-0059
      (Name)   (Area Code)   (Telephone No.)

     

      2. Have all other periodic reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).

     

    ☒ Yes ☐ No

     

      3. Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

     

    ☐ Yes ☒ No

     

    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

    2

     

     

    FOXO Technologies Inc.

    (Name of Registrant as specified in charter)

     

    has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

     

    Date: May 15, 2025 By

    /s/ Seamus Lagan

       

    Seamus Lagan, Chief Executive Officer

     

    3

    Get the next $FOXO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FOXO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FOXO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • FOXO TECHNOLOGIES INC.'S CRITICAL ACCESS HOSPITAL ANNOUNCES EXPANSION OF SERVICES TO INCLUDE WOUND CARE

      WEST PALM BEACH, FLORIDA, May 19, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company") today announced that its critical access hospital, Big South Fork Medical Center in Oneida, Tennessee, is expanding its services by offering wound care services to patients on an inpatient and outpatient basis. The hospital intends to commence such services on June 2, 2025, and expects to complete the reconfiguration of certain space at the hospital and addition of key clinical hires to facilitate this expected start date. The hospital has experienced a growing need for wound care services particularly for diabetic patients who have wounds often characterized by excessiv

      5/19/25 8:05:00 AM ET
      $FOXO
      Life Insurance
      Finance
    • FOXO TECHNOLOGIES INC.'S BEHAVIORAL HEALTH SUBSIDIARY REACHES KEY OPERATIONAL MILESTONES

      WEST PALM BEACH, FLORIDA, May 06, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company") today announced that its behavioral health subsidiary, Myrtle Recovery Centers, Inc., has reached key patient care milestones. Since operations commenced at its Oneida, Tennessee location in August 2023, the facility has seen over 400 patients and has served patients for over 5,000 care days. Robert Merritt, Chief of Executive Officer of Myrtle stated, "We are excited about reaching these important patient care milestones as they are indicative of the strong presence and reputation our facility has for delivering exemplary care for substance use disorder patients in East

      5/6/25 8:05:00 AM ET
      $FOXO
      Life Insurance
      Finance
    • FOXO TECHNOLOGIES INC. ANNOUNCES COMPLETION OF REVERSE STOCK SPLIT

      West Palm Beach, April 29, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company"), today announced that effective 4.01pm Eastern Time, on April 28, 2025, (the "Effective Time"), the Company completed a 1 for 10 reverse stock split of its outstanding common stock. The Company's common stock will open for trading on Tuesday April 29, 2025, on a post-split basis and continue to trade under the symbol FOXO. As a result of the reverse split, every 10 shares of the Company's common stock issued and outstanding on the Effective Time will be consolidated into one issued and outstanding share with no change in the nominal par value per share of $0.0001. No fractional

      4/29/25 10:05:00 AM ET
      $FOXO
      Life Insurance
      Finance

    $FOXO
    SEC Filings

    See more
    • SEC Form 10-Q filed by FOXO Technologies Inc.

      10-Q - FOXO TECHNOLOGIES INC. (0001812360) (Filer)

      5/20/25 10:04:10 AM ET
      $FOXO
      Life Insurance
      Finance
    • SEC Form NT 10-Q filed by FOXO Technologies Inc.

      NT 10-Q - FOXO TECHNOLOGIES INC. (0001812360) (Filer)

      5/15/25 5:00:05 PM ET
      $FOXO
      Life Insurance
      Finance
    • SEC Form EFFECT filed by FOXO Technologies Inc.

      EFFECT - FOXO TECHNOLOGIES INC. (0001812360) (Filer)

      5/7/25 12:15:15 AM ET
      $FOXO
      Life Insurance
      Finance

    $FOXO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Langley Trevor claimed ownership of 1,023,629 shares (SEC Form 3)

      3 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)

      9/12/24 5:28:21 PM ET
      $FOXO
      Life Insurance
      Finance
    • New insider Lagan Seamus claimed ownership of 1,023,629 shares (SEC Form 3)

      3 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)

      9/12/24 5:27:29 PM ET
      $FOXO
      Life Insurance
      Finance
    • Large owner Kr8 Ai Inc. sold $325,000 worth of shares (1,300,000 units at $0.25), closing all direct ownership in the company (SEC Form 4)

      4 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)

      7/24/24 4:00:23 PM ET
      $FOXO
      Life Insurance
      Finance

    $FOXO
    Financials

    Live finance-specific insights

    See more
    • FOXO TECHNOLOGIES, INC., PROVIDES UPDATE ON RECENT ACOMPLISHMENTS AND BUSINESS STRATEGY

      MINNEAPOLIS, MN, Jan. 28, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the "Company"), provides a brief shareholder letter from Seamus Lagan, recently appointed CEO of FOXO on what has been achieved in recent months and what is planned for 2025 and beyond. Dear Fellow Shareholders, Our recent shareholders meeting on January 17th concluded the requirements of 2024 acquisition agreements and resulted in a change of control of the Company. The accomplishments in the second half of 2024 have been key to what we believe is becoming a very successful turnaround of our Company and has created a foundation from which we believe we can build a significant and profitable

      1/28/25 8:05:00 AM ET
      $FOXO
      Life Insurance
      Finance
    • FOXO TECHNOLOGIES INC., PROVIDES UPDATE ON 2024 ACCOMPLISHMENTS AND PLANS FOR REMAINDER OF THE YEAR

      MINNEAPOLIS, MN, Oct. 15, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the "Company" or "FOXO"), provides a shareholder letter from Mark White, Interim CEO of FOXO, on what has been achieved in 2024 and what is planned for the remainder of 2024 and beyond. Dear Fellow Shareholders, 2024 has been an exciting, tumultuous and productive year for us. We believe the accomplishments already completed and that we believe will be achieved before year-end create a foundation from which we can build a successful enterprise that will increase shareholder value. The Company began 2024 with a continued focus on commercializing its epigenetic technology while, at the same ti

      10/15/24 8:30:00 AM ET
      $FOXO
      Life Insurance
      Finance
    • Foxo Technologies, Inc., Completes the Acquisition of Revenue Generating Operations From Rennova Health, Inc.

      MINNEAPOLIS, MN, Sept. 17, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the "Company"), today announced it has completed the acquisition of the second revenue-generating operation from Rennova Health, Inc. (OTC:RNVA) ("Rennova").  The Company had previously announced it had entered into two share exchange agreements with Rennova. The first agreement was to acquire the equity in Myrtle Recovery Centers, Inc., Rennova's behavioral health services subsidiary. Closing of the Myrtle transaction occurred on June 14, 2024. The second agreement was to acquire the equity in Rennova Community Health, Inc. (RCHI), the owner of Scott County Community Hospital, I

      9/17/24 9:00:00 AM ET
      $FOXO
      Life Insurance
      Finance

    $FOXO
    Leadership Updates

    Live Leadership Updates

    See more
    • FOXO TECHNOLOGIES INC. ANNOUNCES RESTRUCTURING AND CAPITAL RAISING TRANSACTIONS AND APPOINTS SEAMUS LAGAN AS CHIEF EXECUTIVE OFFICER

      MINNEAPOLIS, MN, Dec. 11, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the "Company" or "FOXO") announces a series of restructuring and capital raising transactions which will improve the Company's balance sheet, satisfy minimum stockholders' equity requirements of the NYSE American and provide capital for growth and reduce outstanding liabilities. The Company also announces a change in senior leadership. Key transactions include: Rennova Health, Inc.'s exchange of approximately $21 million of a Senior Secured Note issued by Rennova Community Health, Inc., the Company's subsidiary, into 21,000 shares of the Company's Series A Cumulative Convertible Redeemable Pr

      12/11/24 8:00:00 AM ET
      $FOXO
      Life Insurance
      Finance
    • FOXO Technologies Announces Appointment of Capital Markets Veteran Francis Colt deWolf to the Board of Directors

      FOXO Technologies Inc. (NYSE:FOXO) (the "Company"), today announced the appointment of Francis Colt deWolf to the Company's Board of Directors. Mr. deWolf III brings over 20 years of experience in the financial services Sector. He currently serves as President of Colt Capital LLC, a Florida-based company, whose principal activities focus on advising emerging market companies on private and public financing strategies. Prior to founding Colt Capital LLC, Mr. deWolf was a Senior Vice President at Oppenheimer and Company, where he oversaw a variety of financing activities. Mr. deWolf also served as Vice President at Prudential Securities and as a bond broker for Tucker Anthony. Mr. deWolf is

      1/25/24 5:00:00 PM ET
      $FOXO
      Life Insurance
      Finance
    • FOXO Technologies™ Announces Resignation of Taylor Fay, Chief Operating Officer

      FOXO Technologies Inc. (NYSEAM:FOXO), a leader in commercializing epigenetic biomarkers of health and aging, today announced the resignation of Taylor Fay as Chief Operating Officer of the Company, effective April 28, 2023. "I am extremely proud of our achievements throughout Taylor's tenure at FOXO," said Tyler Danielson, interim CEO, and Chief Technology Officer at FOXO. "His leadership and work ethic inspired those around him, and we are a more talented and dedicated team because of his contributions. The Board and executive leadership thank Taylor for his leadership and wish him well in his future endeavors." "Throughout my tenure at FOXO, I have worked alongside an exceptional team

      4/18/23 8:00:00 AM ET
      $FOXO
      Life Insurance
      Finance

    $FOXO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by FOXO Technologies Inc.

      SC 13G/A - FOXO TECHNOLOGIES INC. (0001812360) (Subject)

      11/7/24 8:46:01 AM ET
      $FOXO
      Life Insurance
      Finance
    • Amendment: SEC Form SC 13D/A filed by FOXO Technologies Inc.

      SC 13D/A - FOXO TECHNOLOGIES INC. (0001812360) (Subject)

      9/23/24 4:15:07 PM ET
      $FOXO
      Life Insurance
      Finance
    • SEC Form SC 13D filed by FOXO Technologies Inc.

      SC 13D - FOXO TECHNOLOGIES INC. (0001812360) (Subject)

      8/5/24 4:15:29 PM ET
      $FOXO
      Life Insurance
      Finance